• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本基于医院的癌症登记处和指定癌症治疗医院的覆盖情况。

Coverage of the hospital-based cancer registries and the designated cancer care hospitals in Japan.

机构信息

Center for Cancer Registries, Center for Cancer Control and Information Services, National Cancer Center, Japan.

出版信息

Jpn J Clin Oncol. 2021 May 28;51(6):992-998. doi: 10.1093/jjco/hyab036.

DOI:10.1093/jjco/hyab036
PMID:33851709
Abstract

BACKGROUND

Hospital-based cancer registries were developed to describe and improve clinical care for cancer patients. We described the hospital-based cancer registry coverage as a reference for the users, including researchers, policymakers and clinicians.

METHODS

The hospital-based cancer registry coverage was defined as the proportion of new cases registered in the hospital-based cancer registry to the National Cancer Registry as the denominator. To examine the coverage of respective cancer types, age groups and prefecture in the hospital-based cancer registry, cases were grouped based on the 10th International Statistical Classification of Diseases and Related Health Problems and were compared with the published report of the National Cancer Registry in 2017.

RESULTS

The overall hospital-based cancer registries coverage was 71.7%, and 52.5% of patients were treated at designated cancer care hospitals. The hospital-based cancer registries coverage and treatment rates at designated cancer care hospitals varied per cancer type, age group, and prefecture. The hospital-based cancer registries covered over 80% of the patients with cancers of the larynx, uterus, oesophagus, lip, oral cavity, pharynx and skin, whereas patients' coverage with thyroid cancer was relatively low. The hospital-based cancer registry coverage of young patients (<15 years) was >80%, whereas that for elderly patients (≥85 years) was <55%. The range of coverage in each prefecture was from 43.0 to 89.7%. Over 70% of the patients with cancers of the larynx, lip, oral cavity and pharynx were treated at designated cancer care hospitals.

CONCLUSIONS

The hospital-based cancer registry coverage is ~70% of all cancers. Because the coverage differed across cancers and age groups, the respective target groups' analysis should consider this factor.

摘要

背景

医院癌症登记处的建立旨在描述和改善癌症患者的临床护理。我们描述了医院癌症登记处的覆盖范围,以供用户参考,包括研究人员、政策制定者和临床医生。

方法

医院癌症登记处的覆盖范围定义为医院癌症登记处登记的新病例数占国家癌症登记处的比例。为了检查医院癌症登记处中各癌症类型、年龄组和地区的覆盖范围,根据第十次国际疾病和相关健康问题统计分类对病例进行分组,并与 2017 年国家癌症登记处公布的报告进行比较。

结果

医院癌症登记处的总体覆盖范围为 71.7%,52.5%的患者在指定癌症治疗医院接受治疗。医院癌症登记处的覆盖范围和指定癌症治疗医院的治疗率因癌症类型、年龄组和地区而异。医院癌症登记处覆盖了超过 80%的喉癌、子宫癌、食管癌、唇癌、口腔癌、咽癌和皮肤癌患者,而甲状腺癌患者的覆盖范围相对较低。<15 岁的年轻患者的医院癌症登记处覆盖范围>80%,而≥85 岁的老年患者的覆盖范围<55%。每个地区的覆盖范围从 43.0%到 89.7%不等。超过 70%的喉癌、唇癌、口腔癌和咽癌患者在指定癌症治疗医院接受治疗。

结论

医院癌症登记处的覆盖范围约为所有癌症的 70%。由于癌症和年龄组之间的覆盖范围存在差异,因此各自的目标群体分析应考虑这一因素。

相似文献

1
Coverage of the hospital-based cancer registries and the designated cancer care hospitals in Japan.日本基于医院的癌症登记处和指定癌症治疗医院的覆盖情况。
Jpn J Clin Oncol. 2021 May 28;51(6):992-998. doi: 10.1093/jjco/hyab036.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
4
National incidence and initial therapy for thymic carcinoma in Japan: based on analysis of hospital-based cancer registry data, 2009-2015.日本胸腺癌的国家发病率和初始治疗:基于 2009-2015 年基于医院癌症登记数据的分析。
Jpn J Clin Oncol. 2020 Apr 7;50(4):434-439. doi: 10.1093/jjco/hyz203.
5
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.印度各邦癌症负担及其变化:1990-2016 年全球疾病负担研究。
Lancet Oncol. 2018 Oct;19(10):1289-1306. doi: 10.1016/S1470-2045(18)30447-9. Epub 2018 Sep 12.
6
Three-year survival from diagnosis in surgically treated patients in designated and nondesignated cancer care hospitals in Japan.日本指定和非指定癌症治疗医院手术治疗患者的诊断后 3 年生存率。
Cancer Sci. 2021 Jun;112(6):2513-2521. doi: 10.1111/cas.14847. Epub 2021 May 2.
7
Projection of cancer incident cases for India -till 2026.印度癌症发病病例预测——至2026年。
Asian Pac J Cancer Prev. 2013;14(7):4379-86.
8
Cancer patterns in Karachi (all districts), Pakistan: First results (2010-2015) from a Pathology based cancer registry of the largest government-run diagnostic and reference center of Karachi.巴基斯坦卡拉奇(所有地区)的癌症模式:来自卡拉奇最大的政府运营诊断和参考中心基于病理学的癌症登记处的首批结果(2010 - 2015年)
Cancer Epidemiol. 2016 Oct;44:114-122. doi: 10.1016/j.canep.2016.08.011. Epub 2016 Aug 23.
9
Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016-2018.日本儿童、青少年和青年 2016-2018 年癌症发病率和治疗医院类型。
Cancer Sci. 2023 Sep;114(9):3770-3782. doi: 10.1111/cas.15892. Epub 2023 Jul 6.
10
Time trend analysis of rare cancer incidence 2011-2018: Nationwide population-based cancer registries in Japan.2011-2018 年罕见癌症发病率的时间趋势分析:日本全国基于人群的癌症登记处。
Cancer Sci. 2024 Jul;115(7):2417-2443. doi: 10.1111/cas.16176. Epub 2024 Apr 13.

引用本文的文献

1
Regional disparities in breast cancer healthcare in Japan: REAL-BC study.日本乳腺癌医疗的地区差异:REAL-BC研究
Breast Cancer. 2025 Sep;32(5):1102-1114. doi: 10.1007/s12282-025-01739-x. Epub 2025 Aug 2.
2
Proposal for a New Classification of Rare Cancers Adopting Updated Histological Tumor Types.采用更新后的组织学肿瘤类型对罕见癌症进行新分类的提议。
Pathol Int. 2025 Jun;75(6):291-309. doi: 10.1111/pin.70021. Epub 2025 May 16.
3
Quality indicators for endometrial cancer care in Japan.日本子宫内膜癌护理的质量指标。
J Gynecol Oncol. 2025 Sep;36(5):e77. doi: 10.3802/jgo.2025.36.e77. Epub 2025 Mar 17.
4
Consultations of patients with cancer to enhance shared decision-making in Japan: A retrospective observational study.日本为加强共同决策而开展的癌症患者咨询:一项回顾性观察研究。
Support Care Cancer. 2025 Apr 1;33(4):335. doi: 10.1007/s00520-025-09408-7.
5
Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan.日本宫颈癌质量指标的修订及现有指标的趋势分析。
J Gynecol Oncol. 2025 Sep;36(5):e78. doi: 10.3802/jgo.2025.36.e78. Epub 2025 Mar 5.
6
Differences in experiences of patients with advanced cancer in Japan from 3 to 6 years after diagnosis.日本晚期癌症患者确诊后3至6年的经历差异。
J Cancer Surviv. 2025 Feb 13. doi: 10.1007/s11764-025-01761-0.
7
Surgery lengthens survival for collecting duct carcinoma: analysis of hospital-based cancer registry data in Japan.手术延长集合管癌患者的生存期:日本基于医院癌症登记数据的分析。
BMC Cancer. 2025 Jan 24;25(1):138. doi: 10.1186/s12885-025-13572-8.
8
Comprehensive epidemiology of melanoma at all sites: insights from Japan's National Cancer Registry, 2016-2017.所有部位黑色素瘤的综合流行病学:来自日本国家癌症登记处的见解,2016 - 2017年
Int J Clin Oncol. 2025 Feb;30(2):194-198. doi: 10.1007/s10147-024-02675-0. Epub 2025 Jan 3.
9
Trends of prostate cancer treatment in Ehime Prefecture, Japan: analysis of a hospital-based cancer registry.日本爱媛县前列腺癌治疗趋势:基于医院癌症登记的分析。
BMC Urol. 2024 Nov 9;24(1):248. doi: 10.1186/s12894-024-01646-x.
10
Incidence, mortality, survival, and treatment statistics of cancers in digestive organs-Japanese cancer statistics 2024.消化器官癌症的发病率、死亡率、生存率及治疗统计——2024年日本癌症统计数据
Ann Gastroenterol Surg. 2024 Jun 17;8(6):958-965. doi: 10.1002/ags3.12835. eCollection 2024 Nov.